DPP4 and metabolic dysfunction-associated steatotic liver disease: For instance, a 2.12‐fold increase in dipeptidyl peptidase 4 (DPP4) expression—previously linked to the progression of non‐alcoholic fatty liver disease (NAFLD) [22, 23]—suggests that EC may trigger subtle metabolic shifts.